Skip to main content
. 2017 Feb 13;8:36. doi: 10.3389/fneur.2017.00036

Table 2.

Overview of the eight studies included in the review.

Reference, country Study design Sample Outcome measures Main results
Tass et al. (27), Germany Computer analysis None Coordinated reset (CR) neuromodulation: model presentation illustrating the concept of CR in a simplified neuronal model, considering neurons with spike timing-dependent plasticity transformation of the concept of deep brain stimulation into non-invasive, acoustic CR stimulation Non-invasive acoustic CR neuromodulation may be a novel therapy for tinnitus

Tass et al. (23), Germany Prospective, randomized, single blind, placebo-controlled trial: RESET 63 Visual analog scale (VAS) CR neuromodulation caused a significant decrease of tinnitus loudness and symptoms, and reversed tinnitus-related EEG alterations
Tinnitus Questionnaire (TQ)
Tinnitus frequency
Spontaneous EEG

Adamchic et al. (28), Germany Part of RESET 59 Tinnitus pitch change versus tinnitus loudness and/or annoyance (VAS score) VAS scores significantly correlated with the absolute value of the CR neuromodulation-induced tinnitus pitch change (r = 0.92 baseline to 12 weeks, p < 0.01)
Changes of brain synchrony induced by CR neuromodulation versus tinnitus pitch change Significant changes in brain activity were associated with a pronounced tinnitus pitch change

Adamchic et al. (29), Germany Part of RESET 28 EEG pattern in the tinnitus patients after CR neuromodulation versus EEG pattern in healthy controls Tinnitus patients significantly deviated from healthy controls concerning oscillatory brain activity
EEG in tinnitus patients before and after acoustic CR neuromodulation CR neuromodulation significantly normalized patient’s brain oscillations in all frequency bands
Relationship between CR neuromodulation-induced changes of different resting EEG parameters and tinnitus symptoms CR neuromodulation-induced normalization of EEG power was significantly associated with reduction of tinnitus severity

Silchenko et al. (30), Germany Part of RESET 28 Comparison of EEG in tinnitus patients before and after CR neuromodulation CR neuromodulation significantly normalized both power and causal interactions within a tinnitus-related network
Comparison of EEG in tinnitus patients with healthy controls CR neuromodulation specifically counteracted an imbalance of excitation and inhibition in tinnitus patients
CR neuromodulation qualitatively changed the spectral response of the tinnitus network by modifying the shape of the averaged transfer function, so that the latter became similar to the control group

Adamchic et al. (31), Germany, USA Re-analysis of existing dataset from RESET 59 To investigate how the oscillations in the various frequency bands interact Identification of changes of cross-frequency coupling (CFC)
Phase–amplitude CFC increased in tinnitus patients within the auditory cortex and the dorsolateral prefrontal regions between the phase of delta-theta and the amplitude of gamma oscillations
Theta phase in the anterior cingulate region modulated gamma in the auditory and dorsolateral prefrontal regions

Hauptmann et al. (26), Germany, UK, USA Prospective open-label, non-randomized, non-controlled multicenter clinical study 200 TQ (TBF-12) TBF-12 (total score) showed a mean reduction of 4.1 points (−37.9%) compared to baseline (p < 0.01)
23 study centers Global Clinical Improvement-Impression Scale (CGI-I7) CGI-I7 revealed that 66.9% of the patients reported an improvement of tinnitus [very much improved (8.7%), much improved (25%), or slightly improved (33.2%)] (p < 0.01)
Numeric Rating Scale (NRS) (0–100) Tinnitus-related loudness and annoyance were reduced by 11.1 points (18.9%) and 14.7 points (25.2%), respectively, compared to baseline (p < 0.01) on the NRS

Williams et al. (32), UK, Germany Clinical case study, open-label, non-randomized, non-controlled 66 Tinnitus Handicap Questionnaire (THQ) score VAS scores were significantly improved: 25.8% mean reduction in tinnitus loudness, 32% mean reduction in tinnitus annoyance (p < 0.01 compared to baseline)
VAS for tinnitus annoyance and loudness A clinically significant reduction in tinnitus loudness and annoyance was recorded in 59.1 and 72.7% of the patient group, respectively
THQ scores were significantly improved by an average of 19.4% (p < 0.01)
58.8% of patients experienced a clinically significant reduction in THQ score